EVLiXiR is an innovative biotechnology company developing a powerful drug delivery platform that meets the emerging needs of patients.

Our next-generation technologies achieve high-efficiency loading of drugs (chemical compounds, peptides, proteins, RNAs, and plasmids) into extracellular vesicles (EVs) that are engineered to precisely target specific cells, tissues, and organs.